Doctors often enter practice with a bias shaped by positive portrayals of medications, particularly antidepressants, influenced by pharmaceutical marketing. Concerns about retracted drugs and withdrawal injuries are frequently dismissed by companies and regulatory bodies, leading to a narrative that undermines legitimate risks. This bias can cloud judgment, especially regarding the safety and efficacy of treatments for conditions like depression.
